Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation

被引:4
|
作者
Navarro, Ana Marin [1 ]
Day, Kelly [2 ]
Kogner, Per [3 ]
Wilhelm, Margareta [1 ]
Falk, Anna [2 ]
机构
[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Biomed B7, S-17165 Stockholm, Sweden
[2] Karolinska Inst, Dept Neurosci, Biomed D7, S-17165 Stockholm, Sweden
[3] Karolinska Inst, Dept Womens & Childrens Hlth KBH, S-17177 Stockholm, Sweden
关键词
D O I
10.1016/j.scr.2018.11.017
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Neuroblastoma (NB) is an embryonic tumor of the peripheral nervous system and one of the most common solid cancers in infants. Mutations in the Anaplastic lymphoma tyrosine kinase (ALK) gene are common in NB. To study the contribution of ALK mutations in NB initiation and progression, we reprogrammed fibroblasts from two related NB patients carrying germline mutations in ALK (R1275Q) using non-integrating Sendai virus. The iPS cells are grown in a feeder-and xeno-free conditions, have normal karyotype, retain the ALK R1275Q mutation, have been characterized by expression of pluripotency markers and differentiation to all three germ layers.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Generation of two induced pluripotent stem cell lines carrying the R14del mutation for ARVD/C
    Vera, Carlos D.
    Manhas, Amit
    Shenoy, Sushma P.
    Wheeler, Matthew T.
    Sallam, Karim
    Wu, Joseph C.
    STEM CELL RESEARCH, 2022, 63
  • [2] Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation
    Bonilauri, Bernardo
    Shin, Hye Sook
    Htet, Min
    Yan, Christopher D.
    Witteles, Ronald M.
    Sallam, Karim
    Wu, Joseph C.
    STEM CELL RESEARCH, 2023, 72
  • [3] Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation
    Bonilauri, Bernardo
    Shin, Hye Sook
    Htet, Min
    Yan, Christopher D.
    Wittles, Ronald M.
    Sallam, Karim
    Wu, Joseph C.
    STEM CELL RESEARCH, 2023, 72
  • [4] Generation of two induced pluripotent stem cell lines from blood cells of a prostate cancer patient carrying germline mutation in CHEK2
    Liu, Ran
    Qian, Kaiyu
    Xiao, Yu
    Jiang, Wei
    STEM CELL RESEARCH, 2021, 53
  • [5] Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations
    Zhang, Tina Tianbo
    Zhao, Shane Rui
    Alamana, Christina
    Shen, Mengcheng
    Parikh, Victoria
    Wheeler, Matthew T.
    Wu, Joseph C.
    STEM CELL RESEARCH, 2022, 65
  • [6] Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients
    Caudal, Arianne
    Mondejar-Parreno, Gema
    Vera, Carlos D.
    Williams, Damon R.
    Shenoy, Sushma P.
    Liang, David
    Wu, Joseph C.
    STEM CELL RESEARCH, 2022, 63
  • [7] Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation
    Sun, Junyi
    Ren, Lu
    Rivero, Gabriela Canel
    Xu, Lingyun
    Ladabaum, Uri
    Wu, Joseph C.
    STEM CELL RESEARCH, 2024, 81
  • [8] Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations
    Kojic, Ana
    Kim, Hobin
    V. Guevara, Julio
    Ravada, Sai
    Sallam, Karim
    Wu, Joseph C.
    STEM CELL RESEARCH, 2022, 64
  • [9] Generation of two induced pluripotent stem cell lines from Loeys-Dietz syndrome patients carrying heterologous mutation of TGFBR1
    Shang, Renjie
    Sun, Junyi
    Banuelos, Amira G. Flores
    Zhou, Yang
    Liang, David H.
    Wu, Joseph C.
    STEM CELL RESEARCH, 2025, 83
  • [10] Generation of two induced pluripotent stem cell lines from patients with Down syndrome
    Zhu, Wenjuan
    Liu, Wenqiang
    Yu, Rebecca
    Manning, Melanie
    Romfh, Anitra Waran
    Wu, Joseph C.
    STEM CELL RESEARCH, 2023, 72